Not applicableUnknownNCT01255332What this trial is testingHelicobacter Pylori Immune Thrombocytopenic PurpuraWho this might be right forImmune Thrombocytopenic Purpura Cooperative Study Group A for Hematology 26
Large-scale testing (Phase 3)Looking for participantsNCT07700238What this trial is testingRomiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)Who this might be right forPrimary Immune Thrombocytopenia Amgen 126
Large-scale testing (Phase 3)Study completedNCT00774202What this trial is testingHigher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITPWho this might be right forImmune Thrombocytopenic Purpura Weill Medical College of Cornell University 17
Not applicableNot Yet RecruitingNCT07310342What this trial is testingPhysical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic PurpuraWho this might be right forImmune Thrombocytopenic Purpura University Hospital, Bordeaux 53
Testing effectiveness (Phase 2)Study completedNCT00706342What this trial is testingPilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopenic, Idiopathic Rigel Pharmaceuticals 18
Large-scale testing (Phase 3)Study completedNCT00603642What this trial is testingP3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraWho this might be right forIdiopathic Thrombocytopenic Purpura Amgen 34
Very early researchNot Yet RecruitingNCT07416032What this trial is testingA Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia (ITP) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Large-scale testing (Phase 3)Looking for participantsNCT07233213What this trial is testingAn Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune ThrombocytopeniaWho this might be right forPrimary Immune Thrombocytopenia (ITP) Grand Shuyang Life Sciences (Chengdu) Co., Ltd. 36
Not applicableStudy completedNCT02085993What this trial is testingStudy of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration TrainingWho this might be right forImmune Thrombocytopenic Purpura Amgen 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400250What this trial is testingPhase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of TherapyWho this might be right forPrimary Immune Thrombocytopenia (ITP) Peking Union Medical College Hospital 28
Not applicableStudy completedNCT04070612What this trial is testingNational Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.Who this might be right forCytopeniaAutoimmune Haemolytic AnaemiaThrombocytopenic Purpura, Immune University Hospital, Bordeaux 122
Large-scale testing (Phase 3)Study completedNCT02077192What this trial is testingOpen Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Who this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals 123
Not applicableStudy completedNCT04902807What this trial is testingConception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationWho this might be right forAutoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableStudy completedNCT02042560What this trial is testingStudy of Immune Thrombocytopenia Pathogenesis:Who this might be right forPrimary Immune Thrombocytopenia (ITP) Centre Hospitalier Universitaire Dijon 89
Testing effectiveness (Phase 2)Study completedNCT03524612What this trial is testingAssess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITPWho this might be right forImmune Thrombocytopenic Purpura (ITP) Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT00102739What this trial is testingSB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 99
Testing effectiveness (Phase 2)Looking for participantsNCT06478537What this trial is testingTPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationWho this might be right forImmune Thrombocytopenia Peking Union Medical College Hospital 56
Testing effectiveness (Phase 2)Study completedNCT05279872What this trial is testingZanubrutinib in Patients With ITPWho this might be right forImmune ThrombocytopeniaBruton Tyrosine Kinase Peking University People's Hospital 20
Large-scale testing (Phase 3)Study completedNCT00749112What this trial is testingAlemtuzumab and Rituximab in the Treatment of Refractory Autoimmune CytopeniasWho this might be right forIdiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune Hospital Universitario Dr. Jose E. Gonzalez 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07669675What this trial is testingTPO-RA Plus Baricitinib vs. TPO-RA for ITPWho this might be right forITP - Immune Thrombocytopenia Peking University People's Hospital 100